The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial

导出原文传递

翻译打印收藏纠错

作者： Dirven, Linda ^[1] ; van den Bent, Martin J. ^[2] ; Bottomley, Andrew ^[3] ; van der Meer, Nelly ^[4] ; van der Holt, Bronno ^[5] ; Vos, Maaike J. ^[6] ; Walenkamp, Annemiek M. E. ^[7] ; Beerepoot, Laurens V. ^[8] ; Hanse, Monique C. J. ^[9] ; Reijneveld, Jaap C. ^[10] ; Otten, Aja ^[11] ; de Vos, Filip Y. F. L. ; Smits, Marion ; Bromberg, Jacoline E. C. ; Taal, Walter ; Taphoorn, Martin J. B.

作者单位： Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht Clin Trial Ctr, NL-3508 GA Utrecht, Netherlands ^[1] St Elizabeth Hosp, Dept Oncol, NL-5000 LC Tilburg, Netherlands ^[2] Catharina Hosp, Dept Neurol, NL-5602 ZA Eindhoven, Netherlands ^[3] Isala Klin, Dept Neurol, NL-8000 GK Zwolle, Netherlands ^[4] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, NL-9700 RB Groningen, Netherlands ^[5] Erasmus MC Canc Inst, Clin Trial Ctr, NL-3000 CA Rotterdam, Netherlands ^[6] Erasmus MC Canc Inst, Dept Neurooncol, NL-3008 AE Rotterdam, Netherlands ^[7] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands ^[8] Med Ctr Haaglanden, Dept Neurol, NL-2501 CK The Hague, Netherlands ^[9] Erasmus MC Univ Med Ctr Rotterdam, Dept Radiol, NL-3000 CA Rotterdam, Netherlands ^[10] European Org Res Treatment Canc, Qual Life Dept, B-1200 Brussels, Belgium ^[11]

关键词 Brain tumour Recurrent glioblastoma Health-related quality of life Randomised controlled trial Bevacizumab

发布时间 2015-08-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交